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Abstract
The outer cell wall of yeast is characterized by high levels of β-glucans and mannan-oligosaccharides (MOS), which have 
been linked with beneficial effects on intestinal health and immune status in dogs. In this study, a standardized in vitro 
simulation of the canine gastrointestinal tract (Simulator of the Canine Intestinal Microbial Ecosystem; SCIME) was used 
to evaluate the effect of a Saccharomyces cerevisiae-based product, consisting of 27.5% β-glucans and 22.5% MOS, on the 
activity (as assessed by measurement of fermentative metabolites) and composition (as assessed by 16S-targeted Illumina 
sequencing) of canine intestinal microbiota. The S. cerevisiae-based product was tested at three different dosages, i.e., 
0.5, 1.0, and 2.0 g/d. A dose-dependent fermentation pattern was observed along the entire length of the colon, as shown 
by the increased production of the health-related acetate, propionate, and butyrate for the three concentrations tested 
(0.5, 1.0, and 2.0 g/d). A consistent finding for all three tested concentrations was the increased propionate production 
(P < 0.05) in the simulated proximal and distal colon. These changes in terms of fermentative metabolites could be linked 
to specific microbial alterations at the family level, such as the specific stimulation of the propionate-producing families 
Porphyromonadaceae and Prevotellaceae upon in vitro exposure to the S. cerevisiae-based product. Other consistent 
changes in community composition upon repeated exposure included the decrease in the Enterobacteriaceae and the 
Fusobacteriaceae families, which both contain several potentially opportunistic pathogens. Altogether, the generated data 
support a possible health-promoting role of a product high in β-glucans and MOS when supplemented to the dogs’ diet.
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Introduction
Recently, advances in next-generation sequencing have enabled 
the characterization of the canine gut microbiome and revealed 
that it is highly influenced by the type of diet (Kim et al., 2017), 
indicating that dietary interventions might play a key role 
in canine health. Mannan-oligosaccharides (MOS), generally 
derived from the outer cell wall of Saccharomyces cerevisiae, have 
been a widely studied substrate in association with canine gut 
health (Swanson et al., 2002; Grieshop et al., 2004; Gouveia et al., 
2006). The prebiotic properties of MOS are mainly attributed to 
their role in pathogenic resistance. Numerous pathogenic species 
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contain mannose-specific type-1fimbriae which play a crucial 
role in their adherence to the gut wall, thereby stimulating the 
onset of infection. MOS act as a binding ligand to these type-1 
fimbriae, resulting in the reduction of pathogenic colonization 
in the gastrointestinal tract (Oyofo et  al., 1989; Spring et  al., 
2000). Indeed, Strickling et al. (2000) reported a reduction of the 
opportunistic pathogen Clostridium perfringens in the feces of 
dogs fed a diet supplemented with MOS. Similarly, Middelbos 
et al. (2007) showed a numerical reduction of Escherichia coli in 
the feces of adult dogs fed a yeast cell wall preparation high 
in MOS. Besides lowering the abundance of pathogenic species, 
supplementation of MOS has been shown to beneficially impact 
canine intestinal health by promoting the growth of Lactobacillus 
(Swanson et al., 2002) and Bifidobacterium (Strickling et al., 2000; 
Grieshop et al., 2004) species.
Next to high levels of MOS, the outer cell wall of S. cerevisiae is 
characterized by a high β-glucan content (Manners et al., 1973), 
which also contributes to canine gut health. Depending on the 
source, each β-glucan has a different type of linkage, branching 
structure, solubility, and molecular weight, which largely affect 
their functional properties (Brown and Gordon, 2005; El Khoury 
et al., 2012). The β-glucans derived from yeast typically contain 
a linear backbone of β-1,3-glycosidic linkages substituted with a 
limited amount of β-1,6-linked side chains (Manners et al., 1973; 
Brown and Gordon, 2005). Such β-glucans are known for their 
immunomodulatory activity and have already been shown to 
ameliorate immune status in dogs (Stuyven et al., 2010; Rychlik 
et  al., 2013). Rychlik et  al. (2013) have reported that β-glucans 
derived from S.  cerevisiae alleviated clinical symptoms of 
inflammatory bowel syndrome in dogs by lowering the canine 
inflammatory bowel disease activity index, decreasing levels 
of the pro-inflammatory cytokine IL-6, and increasing anti-
inflammatory IL-10 concentrations. However, few studies have 
focused on the effect of β-glucans on the canine microbial 
community.
Therefore, the aim of this work was to assess the potential 
beneficial effect of a S. cerevisiae-based product, characterized by 
high β-glucan and MOS content, in the modulation of the canine 
gut microbiota and fermentative metabolites, using an in vitro 
simulation of the gastrointestinal tract of dogs.
Materials and methods
Chemicals and test product
All chemicals were obtained from Sigma-Aldrich (Overijse, 
Belgium) unless stated otherwise. The test product BIOLEX MB 
40 (Leiber GmbH, Bramsche, Germany) consisted of 100% of 
the cell walls of S.  cerevisiae and was characterized by 27.5% 
β-glucans and 22.5% MOS. The remaining content of the test 
product included 25% raw protein, 7.5% crude fat, and other 
remaining cell wall components with a 6% moisture content. 
The S.  cerevisiae-based product was tested at three different 
dosages, i.e., 0.5, 1.0, and 2.0 g/d, which would correspond to the 
in vivo recommendation of 0.05 to 0.2 % of the product in pet 
food and livestock feeds.
Simulator of the canine intestinal microbial 
ecosystem
The reactor configuration was adapted from the Simulator of 
the Canine Intestinal Microbial Ecosystem (SCIME; Duysburgh 
et al., 2020), in order to allow the study of three different test 
concentrations of the S.  cerevisiae-based test product in one 
single setup. In the current study, the reactor setup of the 
SCIME consisted of three different segments in order to test 
the three different test concentrations on parallel, with each 
segment consisting of a succession of three reactors simulating 
the different regions of the gastrointestinal tract, i.e., upper 
gastrointestinal tract including subsequent simulation of 
stomach and small intestine, proximal colon (PC), and distal 
colon (DC), respectively. Inoculum preparation, retention times, 
pH, temperature settings, and reactor feed composition were 
previously described (Duysburgh et  al., 2020). The simulated 
nutritional medium, composed of 9 g/L dog food (Hill’s Science 
plan adult advance Fitness Lamb and Rice), 4 g/L mucin, 0.5 g/L 
cystein, 4  g/L special peptone (Oxoid, Aalst, Belgium), and 
1.5 g/L yeast extract (Oxoid, Aalst, Belgium), was supplied to the 
model twice per day, representing a two meals per day feeding 
regime. Upon inoculation of each PC and DC with the microbiota 
derived from fresh fecal matter obtained from a Beagle dog, a 
2-wk stabilization period was initiated to allow the microbial 
community to differentiate in the different reactors depending 
on the local environmental conditions, followed by a 2-wk 
control period to determine the baseline microbial community 
composition and activity. Following the control period, the 
S.  cerevisiae-based test product was administered during each 
feeding cycle on top of the simulated nutritional medium in 
order to reach a daily dose of 0.5, 1.0, or 2.0  g/d over a 3-wk 
treatment period. Additionally, the SCIME setup was modified by 
incorporating a mucosal environment (the so-called M-SCIME), 
which takes into account the colonization of the mucus layer, as 
was previously reported for the human model (Van den Abbeele 
et al., 2012).
Short-term colonic incubations
Given the regular flushing with N2 in the SCIME model to 
ensure anaerobiosis, gas production cannot be monitored in 
the long-term setup. Therefore, short-term colonic incubations 
were performed to evaluate total gas production. The colonic 
incubations were performed in closed penicillin bottles during 
which a single dose of the S. cerevisiae-based test product was 
supplied to a PC microbiota derived from the long-term SCIME 
during the control period. At the start of the colonic incubation, 
a sugar-depleted background medium (5.2 g/L K2HPO4; 16.3 g/L 
KH2PO4; 2.0 g/L NaHCO3; 2.0 g/L yeast extract; 2.0 g/L peptone; 
1.0 g/L mucin; 0.5 g/L l-cysteine HCl; 2.0 mL/L Tween 80) was added 
to the penicillin bottles, which was made anaerobic by flushing 
with N2. To this background medium, a dose corresponding to 
0.5, 1.0, and 2.0 g/d of the S.  cerevisiae-based test product was 
supplemented separately. The negative control consisted of a 
similar incubation without the addition of the S. cerevisiae-based 
test product. Incubations were performed during 48 h, at 39 °C, 
and under continuous shaking (90 rpm). All experiments were 
performed in triplicate. Total gas production (handheld pressure 
indicator CPH6200; Wika, Echt, the Netherlands) was measured 
after 0, 6, 24, and 48 h of colonic incubation. pH measurements 
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(Senseline F410; ProSense, Oosterhout, the Netherlands) were 
performed at the start of the colonic incubation and after 24 and 
48 h.
Microbial metabolic activity
During the control and treatment period of the SCIME experiment, 
samples for microbial metabolic activity were collected three 
times per week from each PC and DC. As described by De 
Weirdt et  al. (2010), short-chain fatty acid (SCFA) production, 
including acetate, propionate, butyrate, and branched-chain 
fatty acids (BCFA) (isobutyrate, isovalerate, and isocaproate), 
was monitored. A  commercially available enzymatic assay kit 
(R-Biopharm, Darmstadt, Germany) was used to determine 
lactate concentrations according to the manufacturer’s 
instructions. Ammonium analysis was conducted as described 
previously (Van de Wiele et al., 2004).
Microbial community analysis
At the end of the control and treatment period of the SCIME 
experiment, samples for microbial community analysis were 
collected from the luminal and mucosal compartment of each 
PC and DC vessel. DNA was isolated as formerly reported 
(Vilchez-Vargas et al., 2013), starting from 1 mL luminal sample 
or 0.1 g mucosal sample. The microbiota profiling of each colon 
compartment was established both at the luminal and at the 
mucosal level. The 16S rRNA gene V3-V4 hypervariable regions 
were amplified by PCR using primers 341F (5′-CCT ACG GGN 
GGC WGC AG-3′) and 785Rmod (5′-GAC TAC HVG GGT ATC TAA 
KCC-3′), with the reverse primer being adapted from Klindworth 
et  al. (2013) to increase coverage. The original genomic DNA 
extracts were diluted in DNase/RNase/protease-free water to 
obtain a concentration of 50 ng/µL, and 30 µL was sent out to 
LGC genomics GmbH (Germany) for library preparation and 
sequencing on an Illumina Miseq platform with v3 chemistry 
with the primers mentioned above.
Statistics
Statistical analysis was performed in GraphPad Prism 8.3.0. 
Normality of data and equality of the variances were determined 
with a Shapiro–Wilk test and a Brown–Forsythe test, respectively. 
For normally distributed data with equal variances, an ANOVA 
with a Tukey post hoc test was used. For normally distributed 
data with unequal variances, a Welch test with a Games–Howell 
post hoc test was conducted. For non-normally distributed data, 
a Kruskal–Wallis ANOVA test with multiple post hoc pairwise 
comparisons was performed. Multiplicity adjusted P-values 
were implemented. In terms of statistics, the differences for all 
data discussed and indicated by P < 0.05 were significant with a 
confidence interval of 95%.
For the 16S-targeted Illumina data, read assembly and 
cleanup were largely derived from the MiSeq procedure as 
previously described (Schloss and Westcott, 2011; Kozich 
et  al., 2013; De Paepe et  al., 2017). In brief, assembly of reads 
into contigs, performance of alignment-based quality filtering, 
elimination of chimeras, assignment of taxonomy using a naïve 
Bayesian classifier (Wang et al., 2007) and RDP release 14 (Cole 
et al., 2009), and clustering of contigs into operational taxonomic 
units (OTUs) at 97% sequence similarity were performed 
using mothur (v. 1.39.5). All sequences classified as Eukaryota, 
Archaea, Chloroplasts, and Mitochondria were removed, as 
were sequences that could not be classified. For each OTU 
representative, sequences were picked as the most abundant 
sequence within that OTU.
Results
Analysis of overall fermentative activity
Gas production is a measure of microbial activity, with changes 
in gas production being indicative for the overall fermentation 
of the S.  cerevisiae-based test product. Treatment with the 
S. cerevisiae-based test product increased gas production during 
all time intervals, with the most pronounced effect observed 
during the first 6 h of incubation (Table 1). Overall, the highest 
gas production was observed for the 2.0 g/d dose (i.e., 40.2 kPa 
after 48  h), reaching significantly higher values as compared 
with the other test conditions (P  <  0.0001, P  =  0.0003, and 
P  =  0.0024 as compared with the blank, 0.5, and 1.0  g/d test 
condition, respectively). The increased gas production upon 
supplementation of the S.  cerevisiae-based test product at a 
concentration of 2.0  g/d was accompanied by a pH decrease 
of 0.09 pH-units during the first 24 h of incubation, though not 
reaching statistical significance as compared with the control 
incubation (Table 1). Also for the other doses tested, acidification 
was not significantly different from the control incubation.
Analysis of the microbial metabolic activity
A dose-dependent fermentation was observed when looking 
at the SCFA profiles, which consisted mainly of acetate, 
propionate, and butyrate (Figure 1) and small amounts of BCFA 
Table 1. Overall metabolic activity in terms of acidification and gas production1 
Parameter Time, h Blank 0.5 g/d 1 g/d 2 g/d
Gas pressure, pKa ∆ 0 to 6 13.0a 14.9b 16.1c 17.9d
(0.5) (0.2) (0.3) (0.3)
∆ 6 to 24 13.3a 14.9a,b 14.9a 16.5b
(0.6) (0.9) (0.4) (0.5)
∆ 24 to 48 4.0a 4.5a,b 5.0a,b 5.8b
(0.3) (1.2) (0.3) (0.5)
pH ∆ 0 to 24 −0.05a −0.06a −0.04a −0.09a
(0.01) (0.02) (0.03) (0.01)
∆ 24 to 48 −0.05a −0.04a −0.04a −0.04a
(0.01) (0.01) (0.01) (0.01)
1pH change between 0 and 24 and 24 and 48 h and increase in gas pressure (kPa) between 0 and 6, 6 and 24, and 24 and 48 h (±stdev) upon 
fermentation of three different concentrations of the S. cerevisiae-based test product (0.5, 1, and 2 g/d) by the canine fecal microbiota vs. the 
respective blank negative control (n = 3). The different test conditions were statistically compared for each experimental parameter and time 
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(Table 2). More specifically, supplementation of 1.0 and 2.0 g/d 
of the S.  cerevisiae-based test product resulted in statistically 
significant increases in acetate production compared with the 
control period in both PC (P = 0.0003 and P < 0.0001, respectively) 
and DC (P  =  0.0372 and P  =  0.0019, respectively), whereas 
no significant effect could be observed for the 0.5  g/d dose. 
Moreover, the strongest effect was observed for the highest 
administration dose with an increased production of acetate 
of 5.5 mM (+ 21%) in PC and 11.9 mM (+ 39%) in DC, reaching 
significance in the PC (P  <  0.0001). Similar observations were 
made for butyrate production, with significant increases being 
observed for the 1.0 and 2.0 g/d treatments as compared with the 
control period in both PC (P = 0.0253 and P = 0.0150, respectively) 
and DC (P = 0.0025 and P < 0.0001, respectively). In the DC, the 
butyrogenic effect was most pronounced upon supplementation 
of 2.0 g/d of the S. cerevisiae-based test product (+2.5 mM [+34%]), 
thereby reaching significantly higher values as compared with 
the lowest administration dose (P  =  0.0013). As for propionate 
production, a statistically significant effect was observed for 
the three administered dosages of the S.  cerevisiae-based test 
product in the PC (P = 0.0019 for the 0.5 g/d and P < 0.001 for the 
1.0 and 2.0 g/d test dose), while in the DC the only significant 
propiogenic effect was observed upon dosing 2.0  g/d of the 
S. cerevisiae-based test product (P < 0.0001), i.e., an increase with 
Figure 1. Microbial metabolic activity in terms of SCFA production. Average acetate (A&B; mM), propionate (C&D; mM), and butyrate (E&F; mM) production over the 
control (C; n = 6) and the treatment (TR; n = 9) period in the PC (left) and DC (right) of the canine gastrointestinal tract. Data are presented as mean ± stdev. Statistically 
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9.3 mM (+58%). Overall, BCFA levels were low (Table 2), with a 
significantly increased production observed upon dosing 1.0 g/d 
of the S. cerevisiae-based test product in both PC (P = 0.0386) and 
DC (P = 0.0019) and upon dosing 2.0 g/d in the DC (P = 0.0033).
Ammonium production remained unaffected, except for a 
significant increase in the PC (P  =  0.0002) and DC (P  <  0.0001) 
upon treatment with the 2.0 g/d dose (Table 2).
Finally, differences in lactate levels were observed during 
the treatment with different dosages of the S.  cerevisiae-based 
test product (Figure 2). Upon dosing 0.5 and 1.0 g/d, a significant 
increase in lactate concentrations was observed in the PC at 
the end of the treatment period as compared with the control 
period (P = 0.0095 and P = 0.0020, respectively), whereas in the 
DC, the test dose of 2.0  g/d resulted in significantly reduced 
lactate levels at the end of the treatment period (P = 0.0294).
Analysis of the microbial community composition
As the three SCIME units were identical prior to treatment, 
starting communities were characterized to compare 
differences between luminal and mucosal microbiota in both PC 
and DC. A phylum-specific colonization of the luminal vs. the 
mucosal compartment was observed (Table  3). Actinobacteria 
were significantly enriched in the mucosal environment in 
both PC and DC, with the main colonization of these phyla 
occurring in the PC. On the other hand, Firmicutes abundance 
was significantly enhanced in the luminal PC and DC. Further, 
tendencies (P > 0.1) to lower abundances in the mucus layer 
for Bacteroidetes and Proteobacteria in PC and Fusobacteria in 
DC were observed. As for the latter phylum, strongly increased 
abundances were observed in the DC as compared with the PC 
in the luminal environment (P = 0.0101). Also a family-specific 
colonization of the lumen vs. the mucus layer was observed 
in the microbial community of the SCIME prior to treatment 
(Table  3). In both PC and DC, Bifidobacteriaceae specifically 
colonized the mucosal environment, whereas Veillonellaceae 
preferred the luminal environment, with the main colonization 
of these families occurring in the PC. Additionally, for families 
mainly colonizing the DC, abundances of Acidaminococcaceae 
and Pseudomonadaceae were higher in the luminal 
compartment, whereas Erysipelotrichaceae, Lachnospiraceae, 
and Sutterellaceae were enriched in the mucus layer.
Upon treatment with the S.  cerevisiae-based test product, a 
consistent increase in the Bacteroidetes phylum was observed in 
the luminal compartment in both PC and DC (Figure 3), reaching 
significance in the DC (P = 0.0067). In the DC, this increase was 
mainly at the expense of the Fusobacteria phylum. At mucosal 
level, no significant changes were observed upon treatment 
with the S. cerevisiae-based test product. At the family level, the 
strongest treatment effects were observed in the luminal (Table 4) 
and not the mucosal environment (Supplementary Table S1). 
The consistent increase of Bacteroidetes (phylum level) in the 
luminal compartment of the SCIME was related to changes in 
three families within this phylum. Indeed, consistent decreases 
in the abundance of Bacteroidaceae were observed in both PC 
and DC upon the addition of the S. cerevisiae-based test product. 
In contrast, Porphyromonadaceae and Prevotellaceae specifically 
Table 2. Microbial metabolic activity in terms of proteolytic markers1
Parameter Colon region
0.5 g/d 1 g/d 2 g/d
C TR C TR C TR
BCFA, mM PC 1.48 2.34a 2.08 3.27a 2.00 2.79a
(0.44) (1.10) (1.13) (0.42) (0.51) (0.30)
DC 3.9 3.94a 3.59 4.16a,b 3.78 4.32b
(0.14) (0.41) (0.37) (0.15) (0.16) (0.17)
NH4
+, mg/L PC 252 258a 265 281a,b 211 317b
(19) (38) (22) (65) (42) (22)
DC 446 422a 424 439a,b 375 469b
(34) (36) (18) (45) (9) (30)
1Average ammonium (NH4+; mg/L) and BCFA (mM) production over the control (C; n = 6) and the treatment (TR; n = 9) period in the PC and DC 
of the canine gastrointestinal tract. Data are presented as mean (±stdev). Statistically significant differences relative to the control period are 
indicated in bold, whereas significant differences between the test conditions are indicated with a different letter (P < 0.05).
Figure 2. Microbial metabolic activity in terms of lactate production. Average lactate (mM) production over two control weeks (C1 and C2; n = 3 per week) and three 
treatment weeks (TR1, TR2, and TR3; n = 3 per week) in the PC (left) and DC (right) of the canine gastrointestinal tract. Data are presented as mean ± stdev. Statistically 
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increased upon supplementation of the S.  cerevisiae-based test 
product. When further analyzing data at the lowest phylogenetic 
level (OTU level) within the Porphyromonadaceae family, it 
followed that two OTUs were mainly responsible for the observed 
increases. These two OTUs were related to Parabacteroides merdae 
(OTU5) and an unclassified Porphyromonadaceae species (OTU19). 
The main family belonging to the Firmicutes phylum was the 
Veillonellaceae family. This family remained unaffected upon 
supplementation of the S.  cerevisiae-based test product. Other 
families within the Firmicutes phylum, such as Lactobacillaceae 
and Lachnospiraceae, decreased upon test product addition. 
On the other hand, the Enterococcaceae family consistently 
increased upon treatment with the S.  cerevisiae-based test 
product in the PC, with the strongest increases observed for 
treatments with the 0.5 and 1.0  g/d doses. The main family 
belonging to the Proteobacteria was the Enterobacteriaceae 
family, which decreased in both PC and DC upon product 
supplementation. This effect was masked at the phylum level 
due to increases of other Proteobacteria families upon treatment, 
i.e., Pseudomonadaceae, Succinivibrionaceae, Sutterellaceae, 
and Xanthomonadaceae. The Actinobacteria phylum consisted 
of Bifidobacteriaceae and Coriobacteriaceae. A  decrease in 
abundance of the Bifidobacteriaceae family was observed upon 
treatment with the S.  cerevisiae-based test product. Finally, as 
was observed at the phylum level (Fusobacteria), treatment with 
the S. cerevisiae-based test product reduced the abundance of the 
Fusobacteriaceae family in the DC.
Discussion
In this study, the effect of repeated dosage of three concentrations 
of a S.  cerevisiae-based test product, characterized by 27.5% 
β-glucans and 22.5% MOS, was assessed in terms of modulation 
of the canine gut microbiota and fermentative metabolites using 
a standardized in vitro gut model using the fecal microbiota of 
a single dog.
By using the Illumina Miseq platform, the starting microbial 
community composition of the dog was analyzed in the in 
vitro SCIME model. At the phylum level, an average community 
composition of 60.1% Firmicutes, 21.4% Bacteroidetes, 9.3% 
Proteobacteria, 7.4% Fusobacteria, and 1.8% Actinobacteria was 
detected when including both the PC and DC compartments of 
the simulated canine gastrointestinal tract, which corresponded 
to the microbial profile recently reported by Duysburgh et  al. 
(2020) using the same in vitro platform. Furthermore, a highly 
similar microbial community composition was obtained as 
was recently reported in vivo (Kim et al., 2017). Indeed, it was 
shown by using the Illumina Miseq platform that the canine 
microbial community composition is significantly affected 
by the type of diet, but that on average, it is composed of 
Firmicutes (64.2% to 73.3%), Bacteroidetes (17.3% to 19.9%), 
Proteobacteria (0.9% to 8.7%), Fusobacteria (0% to 13.6%), and 
Actinobacteria (0.6% to 1.5%) (Kim et  al., 2017). The observed 
similarities with in vivo data provide a good starting point to 
assess the fermentation potential of the S. cerevisiae-based test 
Table 3. Region-specific colonization of starting community1
Phylum Family
Abundance, % P-value
L M L vs. M PC vs. DC
PC DC PC DC PC DC Lumen Mucus
Actinobacteria Bifidobacteriaceae 2.5 1.1 53.9 25.6 0.0156 0.0360  0.0375
Coriobacteriaceae 0.0 0.0 0.8 1.4     
Total 2.5 1.1 54.7 26.9 0.0143 0.0245  0.0372
Bacteroidetes Bacteroidaceae 15.7 13.7 3.3 13.2     
Porphyromonadaceae 0.5 6.4 1.5 10.6     
Prevotellaceae 2.6 4.0 1.0 0.9     
Total 18.7 24.1 5.8 24.8    0.0283
Firmicutes Acidaminococcaceae 0.4 0.9 0.2 0.4  0.0577   
Clostridiaceae_1 0.0 0.0 0.1 4.0     
Clostridiales_unclassified 0.0 0.1 0.0 1.0     
Enterococcaceae 0.0 0.0 0.0 0.0     
Erysipelotrichaceae 0.4 0.1 3.3 2.1  0.0246   
Lachnospiraceae 2.4 2.5 3.6 10.7  0.0176  0.0842
Lactobacillaceae 1.7 0.1 3.1 0.2     
Peptococcaceae_1 0.0 0.0 0.2 1.7     
Ruminococcaceae 0.2 0.2 4.7 4.6     
Veillonellaceae 61.0 49.9 22.6 11.5 0.0034 0.0224 0.0128 0.0791
Total 66.2 53.9 38.0 36.4 0.0189 0.0243   
Fusobacteria Fusobacteriaceae 0.0 14.9 0.0 7.0   0.0101  
Proteobacteria Enterobacteriaceae 11.0 2.8 0.2 0.4   0.0913  
Pseudomonadaceae 1.2 2.2 0.0 0.1  0.0936 0.0205  
Succinivibrionaceae 0.0 0.0 0.4 1.7     
Sutterellaceae 0.0 1.0 0.7 2.7  0.0833 0.0994  
Xanthomonadaceae 0.2 0.0 0.0 0.0     
Total 12.5 6.0 1.5 5.0     
1Average abundance (%) at microbial phylum and family level in the lumen (L) and mucus (M) of the PC and DC of three units of the SCIME 
at the end of the control period (n = 3). Further, also significant differences for a certain family between L and M or between PC and DC are 
indicated by means of their P-value (P < 0.05), as calculated using an ANOVA with post hoc Tukey test for multiple comparisons. Differences 
that were statistically different are indicated by dark gray shading (P < 0.05), while differences that tended to be statistically different are 
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product in the canine gastrointestinal tract using the in vitro 
SCIME model. Furthermore, microbial community development 
in the SCIME model proved to be colon-region specific, as 
was previously reported (Duysburgh et  al., 2020). The PC was 
characterized by an increased abundance of Bifidobacteriaceae 
and Veillonellaceae, while the DC was specifically colonized by 
members of the Fusobacteria phylum. On the other hand, the 
mucosal environment proved to be essential for the growth of 
Bifidobacteriaceae, Erysipelotrichaceae, and Lachnospiraceae, 
the latter being similar as observed by Van den Abbeele et  al. 
(2013) in the human Simulator of the Human Intestinal Microbial 
Ecosystem (SHIME) model. Altogether, these results suggest that 
the use of the in vitro SCIME model provides an accurate model 
to study the fermentation potential of different substrates in the 
canine gastrointestinal tract.
Upon product administration, a stimulation of acetate, 
propionate, and butyrate production was observed upon 
repeated supplementation of the S.  cerevisiae-based test 
product in both the PC and DC, with the strongest effects 
observed for the highest dose tested. A  consistent finding for 
all three tested concentrations was the significantly increased 
propionate production in the PC. It has been shown previously 
that the addition of MOS, derived from the yeast cell wall 
of S.  cerevisiae, to the diet tended to increase ileal propionate 
levels in adult dogs (Strickling et al., 2000). In dogs, propionate 
production has been shown to play a role in satiety through 
the stimulation of gastrointestinal satiety hormones, such as 
Glucagon-like peptide-1 (GLP-1) and Peptide YY. Massimino 
et  al. reported that secretion of GLP-1 by enteroendocrine 
L-cells, which are predominantly present in the distal part of the 
canine gastrointestinal tract (Holst, 2007), was enhanced upon 
supplementation of fermentable dietary fibers in healthy dogs 
(Massimino et  al., 1998). In the current study, the stimulation 
of propionate correlated with the increased abundance of 
the Bacteroidetes phylum. Application of 16S-based Illumina 
sequencing allowed to point out that increases within this 
phylum were related to increases in the Porphyromonadaceae 
and Prevotellaceae, two families containing potent propionate 
producers (Sakamoto, 2014; Krieg, 2011).
With respect to other saccharolytic metabolites, treatment 
with lower concentrations of the S. cerevisiae-based test product 
resulted in initially higher lactate concentrations, indicating the 
stimulation of lactate-producing substrate degraders. Indeed, 
it has been shown that fermentation of MOS by the canine 
microbiota increases lactate concentrations in vitro, suggesting 
the ability of lactate-producing species to utilize MOS as a 
primary substrate (Hussein and Healy, 2001). Application 
of molecular tools showed that likely Enterococcaceae 
were stimulated as main lactate producers (as opposed to 
Lactobacilli and Bifidobacteria). Kim et al. (2017) have shown that 
Enterococcaceae are indeed part of the core microbiome of 
dogs, whereas Bifidobacteriaceae and Lactobacillaceae are not. 
Lactate is considered as a health-promoting metabolite in the 
gut, as it exerts strong antimicrobial effects against pathogens 
(Alakomi et al., 2000; Raybaudi-Massilia et al., 2009). Besides the 
antipathogenic activity, lactate can contribute to health by its 
conversion into butyrate through cross-feeding interactions 
(Bourriaud et al., 2005). In the current study, this was observed 
for the highest dose tested (2.0  g/d), where lactate levels 
significantly decreased during the final weeks of treatment in 
the DC, thereby probably contributing to the increased levels of 
butyrate.
Figure 3. Microbial community composition as assessed via 16S-targeted Illumina sequencing. Abundance (%) at microbial phylum level in the lumen and mucus of 
the PC and DC of the canine gastrointestinal tract over the control (C) and the treatment (TR) period. For optimal observation of consistent effects for the different 
concentrations tested (0.5, 1, and 2 g/d), the average (±stdev) of the three test concentrations is presented (n = 3). Statistically significant differences relative to the 
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Other consistent changes in community composition 
upon product supplementation included the decrease in the 
Enterobacteriaceae and the Fusobacteriaceae families, which 
both contain several potentially opportunistic pathogens. 
Several Enterobacteriaceae species are known to cause disease 
in dogs, including amongst others E.  coli, which is a common 
cause of urinary tract infections in dogs (Sykes, 2013). Previous 
studies have shown that supplementation of the spray-dried 
yeast cell wall to the diet of adult dogs decreases fecal E.  coli 
concentrations in a dose-dependent manner (Middelbos et al., 
2007).
Additionally, increased SCFA production in the DC confirms 
that a proportion of the product had been able to withstand 
fermentation in the PC and was transferred to the DC. Calabrò 
et  al. (2013) have shown that supplementation of the dried 
yeast cell wall to the diet promoted a more distal fermentation 
in the canine gastrointestinal tract in vitro. As saccharolytic 
fermentation mainly takes place in the proximal regions of the 
colon, fermentation in the DC is mainly proteolytic (Williams 
et al., 2001). Considering that proteolytic fermentation can lead 
to the formation of potentially toxic metabolites, such as indoles 
and ammonia, there is great interest in finding substrates with 
biological activity in the DC (Terpend et  al., 2013). Although 
markers of proteolytic fermentation (ammonium and BCFA) 
significantly increased in the DC compartment in the current 
study, probably due to the addition of proteins that were 
contained in the S.  cerevisiae-based test product (i.e., protein 
content of 25%), the distal production of SCFA was an interesting 
finding in this perspective.
A potential shortcoming of the study design includes the 
absence of analysis of interindividual effects among different 
dogs in response to treatment with the S. cerevisiae-based test 
product. Indeed, in the current study, fecal material of one 
Beagle dog was used as microbial inoculum for the in vitro 
platform as the aim was to investigate potential gut-modulatory 
effects of the S. cerevisiae-based test product and not to address 
donor-dependent responses to the treatment. However, it 
has been reported that the composition of the intestinal 
microbiota among dogs can vary considerably (Kim et al., 2017) 
and, therefore, might result in different responses to dietary 
intervention. The inclusion of different animal donors might 
have provided further insight into the effect of the S. cerevisiae-
based test product on the canine microbial community.
From this study, it can be concluded that repeated dosage of 
a product high in β-glucans and MOS affected the gut microbial 
activity and composition in the canine gastrointestinal tract in 
vitro. Changes in terms of metabolic activity could be linked 
to specific microbial alterations at the family level, such as 
the specific stimulation of the propionate-producing families 
Porphyromonadaceae and Prevotellaceae, upon product 
supplementation. The generated data support a possible health-
promoting role of the S.  cerevisiae-based test product when 
supplemented to the dogs’ diet. Further research is warranted 
to confirm these findings.
Supplementary Data
Supplementary data are available at Journal of Animal 
Science online.
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